Squarepoint’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,494
Closed -$367K 2994
2025
Q1
$367K Sell
3,494
-13,305
-79% -$1.4M ﹤0.01% 2082
2024
Q4
$1.8M Buy
+16,799
New +$1.8M ﹤0.01% 1222
2023
Q1
Sell
-3,058
Closed -$204K 2534
2022
Q4
$204K Sell
3,058
-15,910
-84% -$1.06M ﹤0.01% 1884
2022
Q3
$1.02M Buy
+18,968
New +$1.02M 0.01% 1070
2022
Q2
Sell
-12,609
Closed -$885K 2405
2022
Q1
$885K Buy
12,609
+10,514
+502% +$738K ﹤0.01% 1197
2021
Q4
$202K Sell
2,095
-4,928
-70% -$475K ﹤0.01% 2086
2021
Q3
$610K Buy
+7,023
New +$610K ﹤0.01% 1284
2021
Q2
Sell
-7,356
Closed -$700K 2849
2021
Q1
$700K Buy
7,356
+1,555
+27% +$148K ﹤0.01% 1310
2020
Q4
$360K Sell
5,801
-10,093
-64% -$626K ﹤0.01% 1733
2020
Q3
$945K Buy
15,894
+638
+4% +$37.9K 0.01% 981
2020
Q2
$1.06M Buy
+15,256
New +$1.06M 0.02% 901
2020
Q1
Sell
-13,480
Closed -$877K 2178
2019
Q4
$877K Buy
+13,480
New +$877K 0.01% 1391
2019
Q3
Sell
-12,923
Closed -$920K 2418
2019
Q2
$920K Sell
12,923
-8,984
-41% -$640K 0.01% 1289
2019
Q1
$1.72M Sell
21,907
-16,254
-43% -$1.27M 0.02% 841
2018
Q4
$3.23M Buy
38,161
+34,279
+883% +$2.9M 0.04% 521
2018
Q3
$665K Buy
3,882
+1,468
+61% +$251K 0.01% 1176
2018
Q2
$312K Buy
+2,414
New +$312K ﹤0.01% 1363
2017
Q4
Sell
-4,163
Closed -$354K 2215
2017
Q3
$354K Sell
4,163
-8,852
-68% -$753K 0.01% 1090
2017
Q2
$986K Buy
+13,015
New +$986K 0.02% 725
2016
Q1
Sell
-5,179
Closed -$350K 1321
2015
Q4
$350K Sell
5,179
-704
-12% -$47.6K 0.04% 724
2015
Q3
$314K Sell
5,883
-4,537
-44% -$242K 0.08% 263
2015
Q2
$656K Buy
+10,420
New +$656K 0.21% 151